This episode breaks down what GMP and cGMP actually mean, and why broad cGMP claims on RUO peptide websites should be treated with scepticism.

GMP and cGMP are strict quality systems overseen by regulators such as the FDA. They require traceability, documented processes, controlled environments, QA oversight, and inspection. If those controls are missing, the GMP claim falls apart.

A major grey-market tactic is confusing API GMP with finished-product GMP. An API certificate may say something about the raw peptide powder, but it does not prove anything about the final vial: filling, lyophilisation, sterility, storage, or batch release.

The contradiction becomes sharper when products are labelled Research Use Only while also being marketed as cGMP compliant. RUO products sit outside the drug regulatory framework, while cGMP implies regulated manufacturing controls.

A legitimate US cGMP claim should be traceable. At minimum, buyers should be able to ask for the facility name, FEI number, registration status, inspection history, and the scope of what is actually GMP-compliant.

Without that, “cGMP compliant” is not evidence. It’s marketing.